You are here
CCS says no to S$137m Parkway, Fortis deal
THE Competition Commission of Singapore (CCS) said on Monday that it had blocked last week the S$137 million proposed acquisition of RadLink-Asia and its subsidiaries by Parkway Holdings.
Both Fortis Healthcare Singapore, which owns RadLink-Asia, and Parkway, have since
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org